Creo Medical Group plc (LSE: CREO) is a medical device company developing advanced energy-based surgical systems for minimally invasive procedures. Its CROMA platform powers a suite of tools designed for precision cutting and coagulation in gastrointestinal, urology, and oncology applications. Creo aims to improve patient outcomes and reduce procedure costs through next-generation surgical innovation and global clinical adoption. Najnowsze artykuły o akcjach